Teva Pharmaceuticals Usa, Inc.
Federal Contractor · Rank #1919
Spending by Agency
Recent Awards
| Description | Agency | Start Date | Amount |
|---|---|---|---|
| 8510325537!ADENOVIRUS TYPE 4 A | Department of Defense | Dec 14, 2023 | $2.4M |
| 8510559015!ADENOVIRUS TYPE 4 A | Department of Defense | Apr 9, 2024 | $1.6M |
| 8510325475!ADENOVIRUS TYPE 4 A | Department of Defense | Dec 14, 2023 | $1.5M |
| 8510766857!ADENOVIRUS TYPE 4 A | Department of Defense | Jul 19, 2024 | $1.4M |
| 8510688482!ADENOVIRUS TYPE 4 A | Department of Defense | Jun 13, 2024 | $1.4M |
| 8510634433!ADENOVIRUS TYPE 4 A | Department of Defense | May 15, 2024 | $1.4M |
| 8510902080!ADENOVIRUS TYPE 4 A | Department of Defense | Sep 18, 2024 | $1.3M |
| 8510401601!ADENOVIRUS TYPE 4 A | Department of Defense | Jan 25, 2024 | $1.3M |
| 8510839749!ADENOVIRUS TYPE 4 A | Department of Defense | Aug 22, 2024 | $1.1M |
| 8510500489!ADENOVIRUS TYPE 4 A | Department of Defense | Mar 13, 2024 | $1.1M |
| 8510462163!ADENOVIRUS TYPE 4 A | Department of Defense | Feb 22, 2024 | $953K |
| ADENOVIRUS VACCINE EFFICIENCY STUDY. | Department of Defense | Aug 5, 2020 | $929K |
| 8510325476!ADENOVIRUS TYPE 4 A | Department of Defense | Dec 14, 2023 | $916K |
| 8510840306!ADENOVIRUS TYPE 4 A | Department of Defense | Aug 22, 2024 | $635K |
| 8510839844!ADENOVIRUS TYPE 4 A | Department of Defense | Aug 22, 2024 | $635K |
| 8510767083!ADENOVIRUS TYPE 4 A | Department of Defense | Jul 19, 2024 | $635K |
| 8510634439!ADENOVIRUS TYPE 4 A | Department of Defense | May 15, 2024 | $635K |
| 8510634438!ADENOVIRUS TYPE 4 A | Department of Defense | May 15, 2024 | $635K |
| 8510500531!ADENOVIRUS TYPE 4 A | Department of Defense | Mar 13, 2024 | $635K |
| 8510462257!ADENOVIRUS TYPE 4 A | Department of Defense | Feb 22, 2024 | $635K |
All federal spending data sourced from USAspending.gov, the official source for federal award data as mandated by the Government Accountability Office.
Teva Pharmaceuticals Usa, Inc. Federal Contracts FAQ
Teva Pharmaceuticals Usa, Inc. has received $38,516,256 in total federal obligations across 25 awards and 25 contracts.
Teva Pharmaceuticals Usa, Inc. works with 1 federal agencies, including Department of Defense. The largest agency relationships are based on total dollar obligations.
Teva Pharmaceuticals Usa, Inc. has received federal awards in multiple states.
Teva Pharmaceuticals Usa, Inc. is ranked #1919 among the largest federal contractors by total obligation amount. Rankings are based on USASpending.gov data for FY2024.
Explore Other Federal Contractors
Spending figures represent total federal obligations for FY2024, as reported through USASpending.gov. Rankings are based on aggregate obligation amounts across all contract, grant, and direct payment awards.
The this entity record above pulls directly from USASpending.gov federal awards data. What follows is the per-entity context — how this entity sits in the broader U.S. federal government spending distribution and which underlying factors drive the headline numbers.
Every number on this page links back to USASpending.gov federal awards data; the methodology page describes the inputs, refresh cadence, and known limitations of the underlying data product.
For readers using this page as a decision input, the related-entity pages elsewhere on the site provide the comparison set. The most useful comparison for this entity is typically a peer within U.S. federal contracts, grants, and awards with similar size, similar exposure, or similar geography — not the national-level summary alone.